CRAFT: The NCT-PMO-1602 Phase II Trial (#1289)
Laufzeit: 01.01.2022 - 31.12.2040
imported
Kurzfassung
Continuous ReAssessment with Flexible ExTension in Rare Malignancies
Laufzeit: 01.01.2022 - 31.12.2040
Continuous ReAssessment with Flexible ExTension in Rare Malignancies